25 January 2021 - The Therapeutic Goods Administration has granted provisional approval to Pfizer Australia for its COVID-19 vaccine, Comirnaty, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
Following a thorough and independent review of Pfizer's submission, the TGA has decided that this vaccine meets the high safety, efficacy and quality standards required for use in Australia.